Chemomab Therapeutics (CMMB) Operating Leases (2019 - 2025)
Chemomab Therapeutics' Operating Leases was $179,000 in Q1 2025, down 36.1% from $280,000 a year earlier but up 55.7% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Operating Leases (2019 - 2025) Analysis & Trends
At the end of FY2024, Operating Leases at Chemomab Therapeutics came in at $115,000, up 51.3% from FY2023.
- Operating Leases shows a five-year compound annual growth rate of -30.8% (FY2019 to FY2024).
- In earlier years, Operating Leases was $76,000 in FY2023 (-38.2%), $123,000 in FY2022 (-48.1%), $237,000 in FY2021 (-33.8%) and $358,000 in FY2020 (-50.6%).
- Quarterly Operating Leases has moved between $5,000 (Q3 2023) and $358,000 (Q4 2020) over five years.
- Compared with a year earlier, Operating Leases was higher in three of the last seven quarters, with growth averaging 116.5%.
- The best year-over-year quarter for Operating Leases over five years was Q2 2024 (growth of 660.6%); the worst was Q3 2023 (a decline of 95.8%).
- Per Business Quant data, CMMB's Operating Leases in the three quarters before Q1 2025 was $115,000 (Q4 2024), $230,000 (Q3 2024) and $251,000 (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Chemomab Therapeutics | 11.80 Mn | 11.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 179,000.00 |
| Dec 31, 2024 | 115,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 280,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | 62,000.00 |
| Dec 31, 2022 | 123,000.00 |
| Sep 30, 2022 | 118,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 203,000.00 |
| Dec 31, 2021 | 237,000.00 |
| Sep 30, 2021 | 298,000.00 |
| Jun 30, 2021 | 320,000.00 |
| Mar 31, 2021 | 328,000.00 |
| Dec 31, 2020 | 358,000.00 |
| Sep 30, 2020 | 63,000.00 |
| Jun 30, 2020 | 108,000.00 |
API Access
Chemomab Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();